Federal health advisers will vote on whether to withdraw regulatory approval of the Roche drug Avastin for breast cancer treatment after the drug showed disappointing results in recent studies.
Ramius LLC has offered to buy Cypress Bioscience in an all-cash deal. Ramius already owns 9.9 percent of Cypress and said it would buy the rest of the company for $4 per share as it lashed out at the management.
For the first time, a vaginal gel has proved capable of blocking the AIDS virus: It cut in half a woman's chances of getting HIV from an infected partner in a study in South Africa. Scientists called it a breakthrough in the long quest for a tool to help women whose partners won't use condoms.
A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files.
A second Johnson & Johnson medicine factory is under scrutiny from federal regulators, while the company struggles to deal with bad publicity and repeated recalls at another factory.
Drugmaker Pfizer Inc. has stopped patient tests of an experimental drug for two types of pain at the request of federal regulators, just weeks after halting its testing in arthritis patients.
DiTEBA Research Laboratories Inc. and Thesis Chemistry Inc. announced a collaboration that will bring together their proven technical expertise in process chemistry, cGMP chemical production and analytical testing.
CIT, an independent preclinical contract research organization (CRO), is now offering the Dried Blood Spot (DBS) technique to its clients worldwide. The new service is in line with CIT’s policy of continuous enhancements to the range it offers its customers.
AAIPharma Services Corp., a biopharmaceutical drug product development and contract manufacturing company, and CritiTech, Inc., a nanotechnology company that improves the delivery of therapeutic molecules, have announced a strategic alliance to expand the reach of the CritiTech technology.
Dolomite has introduced the modular Syringe-based Droplet Starter System, which enables users to produce more than 10,000 monodispersed droplets per second, ranging from Ø20 to 250µm.
Wyatt Technology Corporation, a leader in absolute macromolecular characterization instrumentation and software, announces the launch of its brand new Refractive Index (RI) detection instrument - the Optilab T-rEX.
Novasep, a leading supplier of manufacturing solutions to the life science industries, and instrAction, a manufacturer of innovative chromatographic stationary phases for API purification processes, announced that they have entered into a strategic alliance.
BioFocus and the University of Bristol announced a new drug discovery collaboration aimed at developing treatments for chronic pain associated with diabetes (diabetic neuropathic pain).
Researchers at Duke University Medical Center have identified a mechanism that could explain how patients move into the worst phase of chronic myelogenous leukemia (CML).